Bcl-2 family protein regulator (Bcl-2 (for the founding member); collectively, "Bcl-2 family" is used)

The Bcl‑2 family protein regulators are a group of evolutionarily conserved proteins that play a central role in controlling apoptosis—the process of programmed cell death—primarily at the level of the mitochondria. Members are classified into two main groups based on function: anti-apoptotic proteins (such as Bcl‑2 itself, Bcl-xL, MCL‑1) that promote cell survival by inhibiting mitochondrial outer membrane permeabilization; and pro-apoptotic members (such as Bax, Bak) that promote cell death. A third subgroup includes BH3-only sensitizer/activator proteins which regulate interactions between these two groups. These regulators determine whether stressed cells undergo apoptosis by integrating various cellular signals. The balance between opposing factions within this family is crucial for normal development and tissue homeostasis; dysregulation contributes to diseases such as cancer—where overexpression can prevent malignant cells from dying—and autoimmunity. The clinical significance is underscored by frequent genetic alterations involving BCL‑2, especially chromosomal translocations seen in lymphomas. Therapeutically, targeting anti-apoptotic members has proven effective in some cancers using small-molecule inhibitors known as "BH3 mimetics." These agents restore apoptotic sensitivity to tumor cells but require careful management due to potential toxicities arising from widespread induction of cell death.

Other names

B-cell lymphoma 2 familyBCL2 familyApoptosis regulator proteins (Bcl-2 related)Anti-apoptotic and pro-apoptotic Bcl-2 proteins

Drugs typically act by inhibiting anti-apoptotic members, thereby promoting apoptosis in cancer cells. This is achieved by mimicking BH3-only proteins to displace pro-apoptotic effectors or directly binding to the hydrophobic groove on anti-apoptotic proteins, neutralizing their function and allowing activation of Bax/Bak-mediated mitochondrial permeabilization.